Covetrus Celebrates Launch as Newly Formed Public Company

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
40
Covetrus Celebrates Launch as Newly Formed Public Company

PORTLAND, Maine, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Today, Covetrus (NASDAQ: CVET ) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global scale to empower veterinarians to enhance clinical and practice health. This means providing veterinary practices with a more comprehensive set of integrated services and technology solutions, tools to strengthen client relationships and grow their practice, while driving improved workflow and cost-effectiveness through efficient delivery of next-generation solutions.

Following the completion of the merger on February 7, today’s announcement marks the launch of Covetrus, which begins regular-way trading on the Nasdaq Stock Market under the symbol CVET this morning.

President and Chief Executive Officer Benjamin Shaw, joined by members of the company’s management team, will celebrate the company’s first day of trading by visiting the exchange and ringing the opening bell at Nasdaq. 

“Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq,” said Mr. Shaw. “We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes.”

More information about the transactions can be found on our Registration Statement Form S-4/S-1 at sec.gov , at  http://www.covetrus.com/investors/sec-filings  and at this link to our  fact sheet .

About Covetrus Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,000 employees, serving over 100,000 customers around the globe.

A PDF accompanying this announcement is available at  http://resource.globenewswire.com/Resource/Do...bdb92421d0

 

Contacts: Kiní Schoop Director, Public Relations 347-302-4453 Nicholas Jansen Vice President of Investor Relations 407-761-8172

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oilfield Chemicals Market Growth Projections for the Future

Updated Category News Views 103

Oilfield Chemicals Market Overview The global oilfield chemicals market, valued at approximately USD 32.07 billion recently, is anticipated to experience substantial growth. Experts project a rise to around USD 50.24 billion by 2034, reflecting a compound annual growth rate (CAGR) of 4.63% between 2025 and 2034. This growth is mainly fueled by increasing energy demands...

Continue Reading
New CFO Amarjeet Singh Joins Australian Oilseeds Holdings

Updated Category News Views 106

Australian Oilseeds Welcomes New Leadership Australian Oilseeds Holdings Limited (NASDAQ: COOT) recently announced a change in its financial leadership with the appointment of Amarjeet Singh as the new Chief Financial Officer (CFO). This strategic move is set to enhance the company's financial management and future growth strategies. Introducing Amarjeet Singh Amarjeet...

Continue Reading
Exciting Recognition for OXB at Global CDMO Leadership Awards

Updated Category News Views 209

Celebrating Excellence in Cell and Gene Therapy OXB, a distinguished contract development and manufacturing organization (CDMO), has been awarded in the 'Cell & Gene Therapy – Global' category at the latest CDMO Leadership Awards. This recognition highlights OXB's commitment to quality and innovation within the burgeoning field of cell and gene therapy, showcasing its...

Continue Reading
Dowlais Group Holdings: Navigating Recent Market Developments

Updated Category News Views 184

Understanding Recent Market Activities of Dowlais Group Holdings In the ever-evolving landscape of finance and investments, companies like Dowlais Group Holdings have carved out a niche for themselves. This article delves deep into the recent disclosures and dealings involving the company's exempt principal trader, Investec Bank plc, which plays a key role in navigating...

Continue Reading
Trinasolar Achieves Milestone with Over 1 GW of Solar Modules

Updated Category News Views 72

Trinasolar's Major Achievement in Solar Energy Delivery Trinasolar has recently announced an impressive milestone, delivering over 1 GW of its Vertex N 720W series solar modules to a significant clean energy project. This important development highlights Trinasolar's commitment to advancing sustainable energy solutions and is poised to support substantial power...

Continue Reading